Glycine reuptake inhibitors for treating drug and alcohol...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/198 (2006.01) A61P 25/30 (2006.01) A61P 25/32 (2006.01) A61P 25/34 (2006.01) A61P 25/36 (2006.01)

Patent

CA 2593274

The invention relates to a method of treatment or prevention of drug addiction, in particular alcoholism, in humans, comprising administering to a subject, in need thereof, an effective amount of a Gly-T1 inhibitor, in particular N-methyl-N-[[(1R,2S)-1,2,3,4- tetrahydro-6-methoxy-1-phenyl-2- naphthalenyl]methyl glycine or a pharmaceutically acceptable salt thereof.

L'invention concerne une méthode visant à traiter ou à prévenir chez l'être humain la dépendance à une drogue, en particulier l'alcoolisme, et qui comprend l'administration à un sujet nécessitant un tel traitement d'une quantité efficace d'un inhibiteur de Gly-T1, notamment la N-méthyl-N-[[(1R,2S)-1,2,3,4- tétrahydro-6-méthoxy-1-phényl-2-naphthalènyl]méthyl glycine ou d'un sel pharmaceutiquement acceptable de ce composé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycine reuptake inhibitors for treating drug and alcohol... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycine reuptake inhibitors for treating drug and alcohol..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycine reuptake inhibitors for treating drug and alcohol... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1426926

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.